Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and effectiveness of 2 doses of the
investigational drug, lasofoxifene, compared to placebo (an inactive substance) in reducing
new spinal fractures in women with osteoporosis.